Advanz Pharma Corp Ltd showcases a strong commitment to its values and corporate philosophy. The company believes in fostering innovation, promoting patient-centricity, and delivering high-quality healthcare products. Advanz Pharma Corp Ltd is focused on maximizing patient access to essential medicines, prioritizing research and development, and maintaining robust ethical standards. With an unwavering dedication to integrity and excellence, Advanz Pharma Corp Ltd continuously strives to improve the lives of individuals worldwide through its exceptional pharmaceutical solutions.

Advanz Pharma Corp Ltd is primarily present in several key countries and regions globally. The company has a significant presence and operations in countries like the United States, Canada, United Kingdom, Germany, France, Spain, Italy, Australia, and New Zealand. Additionally, Advanz Pharma Corp Ltd has a strong market presence in various regions across Asia, including India, China, Japan, and South Korea. With a diverse presence across multiple countries and regions, the company leverages its global footprint to deliver high-quality pharmaceutical products and solutions to patients around the world.

Advanz Pharma Corp Ltd has achieved several significant milestones. Firstly, the company successfully expanded its global footprint by establishing a strong presence in more than 90 countries. Secondly, Advanz Pharma Corp Ltd received numerous regulatory approvals for its high-quality and affordable generic pharmaceutical products, enhancing accessibility to healthcare worldwide. Additionally, the company consistently focuses on research and development, leading to the introduction of innovative therapies and treatment options. Furthermore, Advanz Pharma Corp Ltd has demonstrated strong financial growth and stability, with consistent revenue generation and shareholder value creation. These milestones highlight Advanz Pharma Corp Ltd's commitment to making a positive impact on global healthcare by delivering high-quality and cost-effective pharmaceutical solutions.

Advanz Pharma Corp Ltd is a renowned pharmaceutical company with a rich history and significant background. Established in [year], Advanz Pharma has continuously evolved over the years to become a leader in the pharmaceutical industry. With a focus on innovation, quality, and customer satisfaction, the company has a proven track record of delivering high-quality products and services. Advanz Pharma's commitment to research, development, and growth has propelled them to the forefront of the industry. With a global presence and a dedicated team of professionals, Advanz Pharma Corp Ltd is dedicated to improving healthcare outcomes and enhancing the quality of life for patients worldwide.

The main competitors of Advanz Pharma Corp Ltd in the market include leading pharmaceutical companies such as Pfizer, Novartis, Johnson & Johnson, and GlaxoSmithKline. These companies are renowned for their strong presence and global reach in the pharmaceutical industry. As Advanz Pharma Corp Ltd operates in this competitive market, it strives to differentiate itself through its unique product offerings, advanced research and development, and strategic partnerships. With its innovative approach and dedication to providing high-quality healthcare solutions, Advanz Pharma Corp Ltd continues to compete with its esteemed counterparts in the pharmaceutical sector.

Advanz Pharma Corp Ltd is primarily active in the pharmaceutical industry.

The business model of Advanz Pharma Corp Ltd focuses on the development, manufacturing, and distribution of specialty pharmaceutical products. The company primarily operates in the global generic and specialty pharmaceutical markets. Advanz Pharma Corp Ltd is committed to providing affordable and high-quality medicines to patients worldwide. With a wide range of products, it aims to address diverse therapeutic areas such as central nervous system disorders, oncology, and cardiovascular diseases. Through its strategic partnerships, Advanz Pharma Corp Ltd ensures a robust supply chain and maintains a strong global presence in the pharmaceutical industry.

Količnik cena/dobiček trenutno ni mogoče izračunati za Advanz Pharma Corp.

KUV za Advanz Pharma Corp trenutno ni mogoče izračunati.

AlleAktien Qualitätsscore trenutno ne more biti izračunan za Advanz Pharma Corp.

Prihodki trenutno ne morejo biti izračunani za Advanz Pharma Corp.

Dobička trenutno ni mogoče izračunati za Advanz Pharma Corp.

Advanz Pharma Corp Ltd is a global healthcare company specializing in the development and marketing of generic and specialized pharmaceutical products. The company operates in various business sectors and pursues a diversified business model to strengthen its position as one of the leading players in the pharmaceutical products industry.

Advanz Pharma Corp izplača dividendo v višini 0 USD, razdeljeno na izplačil letno.

Dividende za Advanz Pharma Corp trenutno ni mogoče izračunati ali pa podjetje ne izplačuje dividend.

ISIN od Advanz Pharma Corp je JE00BJVH6L55.

WKN od Advanz Pharma Corp je A2PYQF.

Oznaka delnice Advanz Pharma Corp je CXRXF.

V zadnjih 12 mesecih je Advanz Pharma Corp izplačal dividendo v višini 67,50 USD . To ustreza približni donosnosti dividend 395,66 %. V prihajajočih 12 mesecih bo Advanz Pharma Corp predvidoma izplačal dividendo v višini 0 USD.

Trenutni donos od dividend za Advanz Pharma Corp znaša 395,66 %.

Advanz Pharma Corp izplačuje četrtletno dividendo. Ta se izplačuje v mesecih november, februar, maj, avgust.

Advanz Pharma Corp je v zadnjih 0 letih vsako leto izplačeval dividend.

V naslednjih 12 mesecih se pričakuje dividende v višini 0 USD. To ustreza dividendnemu donosu 0 %.

Advanz Pharma Corp je razvrščen v sektor 'Zdravje'.

Da si prejel zadnjo dividendo Advanz Pharma Corp z dne 29. 7. 2016 v višini 0,075 USD, si moral imeti delnico v depoju pred dnevom brez pravice do dividende (Ex-Tag) 13. 7. 2016.

Zadnje izplačilo dividende je bilo 29. 7. 2016.

V letu 2023 je Advanz Pharma Corp 0 USD izplačal kot dividende.

Dividende od Advanz Pharma Corp se izplačujejo v USD.